Trial · NCT07911072
Dose-Response Effects of Beetroot Juice on Neuromuscular Performance in the Bench Press
NCT07911072, Not applicable, Active not recruiting, Universidad Pontificia Comillas
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Dose-Response Effects of Beetroot Juice on Neuromuscular Performance in the Bench Press. Trials, record NCT07911072. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07911072
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Dose-Response Effects of Beetroot Juice on Neuromuscular Performance in the Bench Press
- NCT number
- NCT07911072
- Status
- Active not recruiting
- Phases
- Not applicable
- Enrollment
- 18 participants, actual
- Lead sponsor
- Universidad Pontificia Comillas
- Conditions
- Beetroot Juice, Placebo
- Interventions
- Nitrate-Rich Beetroot Juice, Nitrate-Depleted Beetroot Juice (Placebo)
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mean Propulsive Velocity During Bench Press at 25% 1RM | During the bench press assessment following supplementation in each of the four experimental sessions. | Mean propulsive velocity (m/s) will be assessed during three repetitions of the bench press exercise performed at 25% of the participant's one-repetition maximum (1RM). |
| Primary | Mean Propulsive Velocity During Bench Press at 50% 1RM | During the bench press assessment following supplementation in each of the four experimental sessions. | Mean propulsive velocity (m/s) will be assessed during two repetitions of the bench press exercise performed at 50% of the participant's one-repetition maximum (1RM). |
| Primary | Mean Propulsive Velocity During Bench Press at 75% 1RM | During the bench press assessment following supplementation in each of the four experimental sessions. | Mean propulsive velocity (m/s) will be assessed during two repetitions of the bench press exercise performed at 75% of the participant's one-repetition maximum (1RM). |
| Primary | Mean Propulsive Velocity During Bench Press at 90% 1RM | During the bench press assessment following supplementation in each of the four experimental sessions. | Mean propulsive velocity (m/s) will be assessed during one repetition of the bench press exercise performed at 90% of the participant's one-repetition maximum (1RM). |
| Primary | Maximum Number of Bench Press Repetitions to Failure at 65% 1RM | During the 65% 1RM repetitions-to-failure test in each of the four experimental sessions. | Muscular endurance will be assessed by recording the maximum number of complete repetitions performed during the bench press exercise at 65% of the participant's one-repetition maximum (1RM) until muscular failure. |
| Secondary | Salivary Nitrate and Nitrite Concentrations | 2.5 hours after supplement ingestion, immediately before exercise, during each of the four experimental sessions. | Salivary nitrite concentration (µmol/L) will be measured to assess changes in nitric oxide-related metabolism (i.e., nitrate and nitrites) following different doses of nitrate-rich beetroot juice supplementation. Saliva samples will be collected 2.5 hours after supplement ingestion, immediately before the start of the exercise protocol, during each of the four experimental sessions |
| Secondary | Salivary Nitrite Concentration | At the protocol-specified saliva collection time points during each of the four experimental sessions. | Salivary nitrite concentration (µmol/L) will be measured to assess changes in nitric oxide-related metabolism following different doses of nitrate-rich beetroot juice supplementation. |
| Secondary | Side Effects Related to Beetroot Juice Supplementation | 24 hours after supplement ingestion, during each of the four experimental sessions. | Potential side effects associated with beetroot juice ingestion will be assessed using a questionnaire consisting of nine items, each answered with "Yes" or "No", to identify the occurrence of supplementation-related symptoms. |
| Secondary | Rating of Perceived Exertion During Bench Press Exercise | 30 minutes after completion of the exercise protocol, during each of the four experimental sessions. | Perceived exertion will be assessed using a rating of perceived exertion (RPE) scale ranging from 1 to 10 points, with higher scores indicating greater perceived effort during the bench press exercise. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07911072
GET https://conductscience.org/api/trials/v1/NCT07911072/registered